Biogazelle
Universiteit Gent

Biogazelle

Biotech
Biotech
Biotech
Biotech

Acquired by CellCarta.

Biogazelle is a Ghent University spin-off founded in 2007 by Jo Vandesompele and Jan Hellemans from the Center for Medical Genetics. Since 2010, Biogazelle offers expert laboratory services in the area of gene expression analysis. To this purpose, several state-of-the-art laboratory methods such as RNA sequencing and digital PCR are being used, complemented with custom developed unique software tools, including qbase+.

No items found.
Marc Zabeau

Marc Zabeau

Managing Partner Qbic I

This company is aligned with the following SDGs

No items found.
MRM Health
Qbic II
Biotech
Biotech
Biotech
Biotech

MRM Health

MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.

Universiteit Gent
Spica Therapeutics
Qbic III
Biotech
Biotech
Biotech
Biotech

Spica Therapeutics

Spica Therapeutics is pioneering Macrophage-Subset targeted therapies

VUB
THERAtRAME
Qbic III
Biotech
Biotech
Biotech
Biotech

THERAtRAME

THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.

ULiège